Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

  • Technology appraisal guidance
  • TA1055
  • Published: 

History

Documents created during the development process.

Declaration of interests

Final draft guidance

Draft guidance: 1

Invitation to participate

Draft scope documents